![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
5 Ann Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
A complete response with daratumumab, venetoclax, azacitidine and dexamethasone
in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic
leukemia/lymphoma patient.
Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-024-06118.
PubMed
Abstract available
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia
undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase
inhibitors: development and validation of a clinical prediction model based on
cytogene
Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-025-06202.
PubMed
Abstract available
How to combine multiple tools for the genetic diagnosis work-up of pediatric
B-cell acute lymphoblastic leukemia.
Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-024-06151.
PubMed
Abstract available
Telomere shortening in donor cell-derived acute promyelocytic leukemia after
allogeneic hematopoietic stem cell transplantation: a case report.
Ann Hematol. 2025 Jan 22. doi: 10.1007/s00277-025-06222.
PubMed
Abstract available
Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia
patient and its implications for clinical treatment.
Ann Hematol. 2025 Jan 21. doi: 10.1007/s00277-024-06169.
PubMed
Abstract available
Dual Biological Role and Clinical Impact of De Novo Chromatin Activation in
Chronic Lymphocytic Leukemia.
Blood. 2025 Jan 22:blood.2024025396. doi: 10.1182/blood.2024025396.
PubMed
Abstract available
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
Blood. 2025 Jan 22:blood.2024025761. doi: 10.1182/blood.2024025761.
PubMed
Abstract available
CD44-Mediated Metabolic Rewiring is A Targetable Dependency of IDH-Mutant
Leukemia.
Blood. 2025 Jan 22:blood.2024027207. doi: 10.1182/blood.2024027207.
PubMed
Abstract available
CpG island methylator phenotype classification improves risk assessment in
pediatric T-cell Acute Lymphoblastic Leukemia.
Blood. 2025 Jan 22:blood.2024026027. doi: 10.1182/blood.2024026027.
PubMed
Abstract available
Myeloablative conditioning in cord blood transplantation for acute myeloid
leukemia patients is efficacious only until age 55.
Bone Marrow Transplant. 2025 Jan 21. doi: 10.1038/s41409-025-02508.
PubMed
Abstract available
Adherence to 6-Mercaptopurine (6-MP) and Habit Strength in Pediatric Acute
Lymphoblastic Leukemia (ALL).
Eur J Haematol. 2025 Jan 20. doi: 10.1111/ejh.14386.
PubMed
Abstract available
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and
aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic
leukemia.
Int J Hematol. 2025 Jan 23. doi: 10.1007/s12185-025-03915.
PubMed
Abstract available
Presence of minimal residual disease determined by next-generation sequencing is
not a reliable prognostic biomarker in children with acute lymphoblastic
leukemia.
Leuk Lymphoma. 2025 Jan 22:1-8. doi: 10.1080/10428194.2025.2456100.
PubMed
Abstract available
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.
Leuk Lymphoma. 2025;66:270-278.
PubMed
Abstract available
New treatments for adult T-cell leukemia/lymphoma.
Leuk Res. 2025;149:107642.
PubMed
Abstract available
Targeted antibody therapy as a treatment strategy for aggressive adult T-cell
leukemia/lymphoma.
Leuk Res. 2025;149:107653.
PubMed
Abstract available
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in
early T-cell precursor acute lymphoblastic leukemia.
Leukemia. 2025 Jan 23. doi: 10.1038/s41375-024-02491.
PubMed
Abstract available
TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute
lymphoblastic leukemia.
Leukemia. 2025 Jan 21. doi: 10.1038/s41375-025-02513.
PubMed
Abstract available
Thank you for your interest in scientific medicine.